norUrsodeoxycholic acid

DB16260InvestigationalSmall molecule

norUrsodeoxycholic acid is under investigation in clinical trial NCT03872921 (Norursodeoxycholic Acid vs Placebo in PSC).

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor gamma
Curator reviewed
Formula / weight: C₂₃H₃₈O₄ · 378.553 g/mol (avg)
Also known as: 24-norursodeoxycholic acid · Nor-ursodeoxycholic acid · Norucholic acid

Resolves to

Compound

UNII8A5G600D9VCAS99697-24-2ChEMBLCHEMBL1254990

Structure

InChIKeyQYYDXDSPYPOWRO-JHMCBHKWSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC(O)=O

Targets

P37231PPARG

What you can answer from here — as of July 25, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with norUrsodeoxycholic acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account